USING LARGE DATABASES AND COMPUTERS TO STUDY HEALTH PROBLEMS and July 12, 2010.

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

CHAPTER © 2011 The McGraw-Hill Companies, Inc. All rights reserved. 2 The Use of Health Information Technology in Physician Practices.
Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,
Opportunities to Leverage HIT for Medicaid Reform in New York Rachel Block, United Hospital Fund C. William Schroth, NYS Department of Health eHealth Initiative.
Disease State Management The Pharmacist’s Role
Department of Vermont Health Access Vermont Blueprint for Health: Using APCD to Evaluate Health Care Reform Pat Jones, MS Blueprint Assistant Director.
Overview Clinical Documentation & Revenue Management: Capturing the Services Prepared and Presented by Linda Hagen and Mae Regalado.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
Technician Training and Roles in Institutional Pharmacy Practice Cindy Wilson, Pharm.D. Harborview Medical Center.
2 The Use of Health Information Technology in Physician Practices.
Healthy People 2010 Focus Area 17: Medical Product Safety Progress Review October 19, 2007.
University of Southern California Department of Pharmaceutical Economics and Policy 1540 E. Alcazar Street, CHP 140 Los Angeles, CA
Research and analysis by Avalere Health Hospitals Demonstrate Commitment to Quality Improvement October 2012.
Clinical Pharmacy Basma Y. Kentab MSc..
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Pharmacy Administration By Dr. Shaimaa Mahmoud Nashat Canadian equivalent Master Degree in Clinical Pharmacy - Toronto University – Canada Canadian Board.
By: Fiona Lane. History The AHA was founded in 1898 The AHA provides education for health care leaders and is a source of information on health care issues.
DSaRM Advisory Committee May 18, 2005 Active Surveillance for Drug Safety Signals: Past, Present, and Future Mary Willy, Ph.D. Division of Drug Risk Evaluation.
Making Large Data Sets Work for You Advantages and Challenges Lesley H Curtis Soko Setoguchi Bradley G Hammill.
History of Health IT Unit 3 Lesson 1
1 NATIONAL ADVISORY COUNCIL ON HEALTHCARE RESEARCH AND QUALITY Subcommittee on Quality Measures for Children's Healthcare in Medicaid and CHIP Overview.
RECENT EFFORTS BY CMS TO INCREASE IMMUNIZATION RATES AMONG MEDICARE BENEFICIARIES National Vaccine Advisory Committee Meeting James Randolph Farris, M.D.
Healthcare Reforms and Pharmaceuticals Lessons from Turkey Prof. Dr. Mehtap Tatar Hacettepe University Faculty of Economics and Administrative Sciences.
Affordable Care Act Aging Network Opportunities Judy Baker Regional Director Health and Human Services October 18, 2010.
The Use of Health Information Technology in Physician Practices
West Coast University NURS 204
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
Pharmaceutical Economics Heng-Sim Lee RPh MS Director of Pharmacy, ChiaYi Branch, Taichung Veterans General Hospital Clinical Nutritional.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Improving Care for Medicare-Medicaid Enrollees Medicare-Medicaid Coordination Office Centers for Medicare & Medicaid Services August 19, 2015.
Diabetes Disease Management Results in Hispanic Medicaid Patients Esteban R. López, MD, MBA, FAAP Program Director and Medical Director, McKesson Health.
Accessing Aggregated Population Health Data from Select Tools of the NCHS A presentation at the Knowledge 4 Equity Conference James M. Craver November.
1 Jan Eldred Karen W. Linkins Lisa Mangiante December 10, 2008.
Occupational Medicine Recognized Specialty Since 1949 Combines Clinical Skills With Toxicology, Epidemiology, Safety, Rehabilitation, and Business Operations.
PROPRIETARY NAME EVALUATION AT FDA Jerry Phillips, RPh Associate Director for Medication Error Prevention Office of Drug Safety December 4, 2003.
TORFAEN MEDICATION ADMINISTRATION SCHEME Val Bessell Wendy Tyler-Batt.
Florida Agency for Health Care Administration Florida Center for Health Information and Policy Analysis Florida Public Health Association - Medical Director’s.
Vermont Department of Banking, Insurance, Securities and Health Care Administration Act 53 of 2003 Hospital Community Reports Community Needs Assessments.
July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.
AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009 Health Information Technology for Economic and Clinical Health Act (HITECH Act) Regina.
Chapter 6 – Data Handling and EPR. Electronic Health Record Systems: Government Initiatives and Public/Private Partnerships EHR is systematic collection.
Exploratory Analysis of Observation Stay Pamela Owens, Ph.D. Ryan Mutter, Ph.D. September, 2009 AHRQ Annual Meeting.
Applying Science to Transform Lives TREATMENT RESEARCH INSTITUTE TRI science addiction Mady Chalk, Ph.D Treatment Research Institute CADPAAC Conference.
Jonathan H. Watanabe, PharmD, MS, PhD Research Interests Analysis of health services use and costs for patients without access to medications (applying.
Population-Based Epidemiologic Safety Studies: Overview and Challenges Drug Safety and Risk Management Advisory Committee Silver Spring, Maryland June.
Medication Therapy Management Programs in Community Pharmacy Community Pharmacy October 17, 2006 Kurt A. Proctor, Ph.D., RPh Chief Operating Officer Community.
Focus Area 17: Medical Product Safety Progress Review November 5, 2003.
Background Objectives Results Methods Within State Geographic Variation in Antipsychotic Medication Treatment for Medicaid-insured Children and Adolescents.
© 2004 Moses & Singer LLP HIPAA and Patient Privacy Issues Raised by the New Medicare Prescription Drug Program National Medicare Prescription Drug Congress.
Stephen W. Schondelmeyer, Pharm.D.,Ph.D. Head, Dept. of Pharmaceutical Care & Health Systems Professor & Director, PRIME Institute CMC Endowed Chair in.
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress 1 How to Implement a Private Payer Reimbursement Strategy Barbara Grenell.
Who are Health-System Pharmacists? Pharmacists are healthcare professionals with extensive education and training in the pharmaceutical sciences. Education.
San Diego Long Term Care Integration Project LTCIP Planning Committee October 11, 2006.
Technology, Information Systems and Reporting in Pharmacy Benefit Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February.
What is Managed Care Pharmacy? Developed by AMCP Membership Committee
Collaboration Network in Healthcare E-RISE 2011 By Yudistira Asnar, Federica Paci (UNITN) May 13, 2011.
Health Departments and HIV Screening Institute of Medicine Workshop 1: Screening and Access to Care April 15, 2010 Natalie Cramer, Associate Director,
Presentation Developed for the Academy of Managed Care Pharmacy
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Expanding the Reach of Evidence in Nova Scotia Can we get the Evidence to Everyone? CADTH Symposium 2016 Lisa Farrell- Chair of DEANS ( NS Liaison CADTH)
Medicaid Influence in the Drug Market Dana Costea PhD student, Department of Economics, Lehigh University Franklin Carter Assistant Professor, Marketing.
Pediatric Asthma Hospitalizations: Impact of Managed Care in the Patterns of Outpatient Healthcare Utilization Capriles, JA., Rodríguez, MH., Rios, R.,
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
CIS 170 MART Teaching Effectively/cis170mart.com FOR MORE CLASSES VISIT HCA 497 MART Inspiring Minds/hca497mart.com FOR MORE CLASSES.
U.S. Administration on Aging 1 U.S. Department of Health and Human Services Administration on Aging Dr. Michelle M. Washko, PhD November 18, 2010 – 8:30.
HCA 497 MART Experience Tradition /hca497mart.com FOR MORE CLASSES VISIT
67th Annual HSFO Conference Louisville, KY
FDA Sentinel Initiative
Using Large Databases for Research
Presentation transcript:

USING LARGE DATABASES AND COMPUTERS TO STUDY HEALTH PROBLEMS and July 12, 2010

University of Mississippi School of Pharmacy 6 academic departments Medicinal Chemistry, Pharmaceutics, Pharmacognosy, Pharmacology, Pharmacy Administration, Pharmacy Practice 2 research centers in the Research Institute of Pharmaceutical Sciences (RIPS) National Center for Natural Products Research (NCNPR) Center for Pharmaceutical Marketing and Management Research (CPMM) Slide 2

CPMM/PHAD research project staffing RIPS/ CPMM personnel 2 Research faculty (PhD) – all have joint appointment in Pharmacy Administration 2 Support staff Pharmacy Administration personnel 6 Faculty (PhD) – all have joint appointment in CPMM 14 MS and PhD graduate students (7 receive stipend support from RIPS and CPMM) Close collaborative relationship with Medical Marketing and Economics (MME) a local pharmaceutical marketing consulting company (4 of 5 starting partners are PHD graduates of Pharmacy Administration department) Slide 3

We do research on a broad assortment of topics? We study everything related to: The selection and use of pharmaceutical products. Medication use patterns and trends in markets. How marketing affects product selection. How product selections are made and what influences the decisions of the various players involved. How medication use and use behaviors (e.g., compliance) affect health outcomes. The development and provision of pharmacy services. Pharmacists job satisfaction. What services are being delivered and by whom. How to better deliver pharmacy services. The economic viability of community pharmacies. How pharmacy services affect health outcomes. Slide 4

Research with administrative claims data is becoming an increasingly important area FDA Sentinel program launched recently to identify and evaluate potential safety problems with approved drugs. Medicare and PBMs evaluating cost/outcomes of plan designs in order to determine the most cost-effective coverage. CMS-Medicare identifying effective medication use quality measures for intervention through Quality Improvement Organizations. AHRQ and other organizations interest in comparative effectiveness studies for treatment alternatives – medications within class and medications across classes. Gradual movement toward true “evidence-based” medical decision making. Slide 5

CPMM -- building access for UM researchers to administrative claims data Current data repositories: 2002 – 2004 MS Medicaid data for all beneficiaries – installed and operational – 2007 Medicare data for 5% national sample of beneficiaries – installed and operations. Other data being obtained this year (target date of Octorber): 2005 – 2007 MS Medicaid data for all beneficiaries – 2007 Medicare data for MS residents 2008 Medicare data for 5% national sample of beneficiaries. Slide 6

Major technology challenges with pharmacoepidemiology research Data management of large multiple linked files Typical health administrative claims data files Beneficiary information Prescription drug claims Institutional short-stay inpatient claims Institutional outpatient claims Medical care claims Long-term care claims Any number of claims of each type for each beneficiary Millions of beneficiaries HIPAA and the Privacy Rule “Research identifiable data” standards Slide 7

CPMM procedure for research repositories containing personal health information (PHI) Identifier fields encrypted and modified as needed to create limited data set files. Identified PHI data obtained on CD / DVD Original disks stored in safe When DUA expires, disks are returned or destroyed – files on research network deleted. Data moved to restricted network using external physical device. Data accessed and analyses run on restricted network server. Restricted Network Computer (maintained by CPMM) Authorized Researchers Only output files can be downloaded for report development. Stand-alone Secure Computer (maintained by CPMM) Slide 8

Examples of Recent and Current Projects

Pharmacoepidemiology projects funded during last two years Intervention and Support Work Using Integrated Medicare Data (funded by CMS – IQH) Examined hospitalization, ED visits and death related to proposed medication use quality measure for the Medicare program. Examination of Medication Use Quality Measures in Mississippi Medicaid Population (funded by CMS-ORDI). Examined hospitalization, ED visits and death related to proposed medication use quality measure for the Medicare program. Using Medicare Claims Data to Evaluate Medication Utilization and Safety in the Elderly Population (funded by HRSA-OHIT) currently underway Examining changes in medication use behaviors and health outcomes related to patients entering the doughnut hole for Medicare Part D coverage. Examining the use of Medicare claims data for assessing FDA safety signals. Slide 10

Pharmacoepidemiology projects funded during last two years Using Medicare/Medicaid Claims Data to Support Medication Outcomes and Pharmacovigilance Research (funded by CMS-ORDI) currently underway Examining the application of national pharmacy quality measures among Mississippi pharmacies using Medicaid and Medicare data. Examining the effect of the Mississippi Medicaid prescription cap on medication use behaviors and outcomes. Evaluating the relationships among medication utilization and adherence and health outcomes in elderly, post myocardial infarction (MI) patients as secondary prevention following a myocardial infarction. Database Study to Evaluate the Impact of Multiple Sclerosis in a Medicare Patient Population (funded by EMD Serono) contract currently being finalized Will examine treatment patterns, adherence and outcomes among Medicare beneficiaries with multiple sclerosis. Slide 11

Podium presentation: 2009 International Society for Pharmacoeconomics and Outcomes Research, Orlando, FL. Presenters: Yi Yang, Vennela Thumula, Pat Pace, Ben Banahan, Noel Wilkin, Bill Lobb Slide 12

Poster presentation: 2009 International Society for Pharmacoeconomics and Outcomes Research, Orlando, FL. Presenters: Krutika Jariwala, Ben Banahan, Yi Yang, Pat Pace Slide 13

Poster presentation: 2009 International Society for Pharmacoeconomics and Outcomes Research, Orlando, FL. Presenters: Yi Yang, Vennela Thumula, Pat Pace, Ben Banahan, Noel Wilkin, Bill Lobb Slide 14

Poster presentation: 2010 American Pharmacists Association Annual Meeting, Washington, DC. Presenters: Matt Hill, Yi Yang, Vennela Thumula, Pat Pace, Ben Banahan, Noel Wilkin Slide 15

Poster presentation: 2010 International Society for Pharmacoeconomics and Outcomes Research, Atlanta, GA. Presenters: Ben Banahan, Clive Mendonca, Amod Athavale, John Bentley Slide 16

Poster presentation: 2010 International Society for Pharmacoeconomics and Outcomes Research, Atlanta, GA. Presenters: Ben Banahan, Pat Pace Slide 17

Questions and Comments